Last Updated 23 July 2021.
2 Vaccines Approved for Use in Hong Kong
-
Pfizer/BioNTech
BNT162b2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 97 countries
29 trials in 16 countries
Approval Source: reuters.com
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 39 countries
16 trials in 7 countries
Approval Source: reuters.com
4 Vaccines in Clinical Trials in Hong Kong
-
Pfizer/BioNTech
BNT162b2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 97 countries
29 trials in 16 countries
-
Oxford/AstraZeneca
AZD1222- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 119 countries
33 trials in 19 countries
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 39 countries
16 trials in 7 countries
-
The University of Hong Kong
DelNS1-nCoV-RBD LAIV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country